- This event has passed.
MediWound to Ring NASDAQ Closing Bell
February 5, 2015
MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, will visit the Nasdaq MarketSite in Times Square in recognition of Burn Awareness Week.
In honor of the occasion, Gal Cohen, Chief Executive Officer will ring the Closing Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Thursday, February 5, 2015 – 3:45 p.m. to 4:00 p.m. ET
A webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx.
About MediWound Ltd.
Based in Yavne, MediWound Ltd. is a biotechnology niche specialty company focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s first innovative biopharmaceutical product, NexoBrid, received marketing authorization from the European Medicines Agency for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns. NexoBrid represents a new paradigm in burn care management, and clinical trials have demonstrated with statistical significance its ability to non-surgically and rapidly remove the eschar earlier and without harming viable tissues.